Chronic Total Occlusion Summit 2018

A Live Case Demonstration Course

FEBRUARY 15-16, 2018

New York Marriott Marquis I 1535 Broadway I New York, NY


Leading practitioners of percutaneous coronary intervention must become experts at recanalizing chronic total occlusions (CTOs), and with advanced techniques, success rates greater than 90% may be obtained. Achieving high success rates with minimal complications is dependent upon physicians being up-to-date on the most recent advances in operator technique, guidewire technology, and other adjunctive devices.

Bringing together leaders in the field of CTO, the Chronic Total Occlusion Summit: A Live Case Demonstration Course will be held in the heart of New York City.

Sessions will emphasize both advanced techniques and evidence-based medicine, with a heavy reliance on live case transmissions featuring the world’s leading experts in CTO PCI. Topics to be covered include:

Fundamentals of CTO PCI
Complex Retrograde and Antegrade CTO PCI
Complication Prevention and Management
How to Improve Outcomes Today
Newest CTO and Complex PCI Techniques and Technologies
Application of CTO PCI Techniques and Technologies in Non-CTO PCI Cases
2017 Essential CTO Updates
Live Case Transmissions
Edited Taped Case Presentations

Learning Objectives

By the end of this course, participants should be able to:

  • Identify the pathobiologic and clinical considerations associated with successful recanalization of chronic total occlusions
  • Explain how advances in operator technique, guidewire technology, and new devices have improved success rates for chronic total occlusions
  • Describe advanced guidewire techniques and other adjunctive devices, including the retrograde technique
  • Integrate the latest recommendations on how to use new guidewires and devices to optimize procedural success, while minimizing complications

Target Audience

This program is designed for interventional cardiologists, endovascular specialists, clinical cardiologists, catheterization laboratory nurses, cardiovascular technologists, and other healthcare professionals with a special interest in the field of chronic total occlusion.

Activity Evaluation

Evaluation will address content, presentation, possible bias, and future educational needs.

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.

CME Accreditation and Designation

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluations. Certificates of attendance are provided to all registered attendees in their meeting materials.